Effects of Holy-Comod and Tears Naturale Forte in Patients After Phaco+IOL
NCT02817191 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2016-11-28
Summary
The purpose of the study it to compare the effects of Holy-Comod and Tears Naturale Forte on ocular surface and tear inflammatory mediators in patients after Phaco+IOL.
Conditions
- Age-related Cataract
Interventions
- DRUG
-
Hylo-Comod eye drop
The patients were administrated Hylo-Comod eye drop four times a day after Phaco+IOL
- DRUG
-
Tears Naturale Forte eye drop
The patients were administrated Tears Naturale Forte eye drop four times a day after Phaco+IOL
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Xingwu Zhong, MD, PhD · Zhongshan Ophthalmic Center, Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Max Age
- 72 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2016-11-30
- Completion
- 2016-11-30
Countries
- China
Study Locations
More Related Trials
-
Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
NCT00485108 ·Status: COMPLETED ·Phase: NA
-
Dextenza for Post-operative Treatment of Pterygium
NCT04351737 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
NCT02951351 ·Status: COMPLETED ·Phase: NA
-
A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms
NCT02028754 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of Felbinac Trometamol Eye Drops
NCT05085106 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Systemic Oxygen on Corneal Epithelial Wound Healing in Diabetic Patients Undergoing Pars Plana Vitrectomy
NCT02344732 ·Status: COMPLETED ·Phase: NA
-
Effect of Topical and Oral Diclofenac on Pain Related to Intravitreal Injections
NCT02837770 ·Status: COMPLETED ·Phase: NA
-
Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period
NCT07090044 ·Status: COMPLETED ·Phase: PHASE4
-
Measurement of Antioxidant Activity on Postoperative Inflammation in Patients Undergoing Ophthalmic Surgery
NCT05905237 ·Status: COMPLETED
-
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
NCT03740659 ·Status: COMPLETED ·Phase: PHASE2
-
Postoperative Discomfort and Ocular Redness Following Phacoemulsification Surgery
NCT02558218 ·Status: COMPLETED ·Phase: NA
-
The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo
NCT03125785 ·Status: UNKNOWN
-
To Compare the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Reducing Rates of Endophthalmitis Following Cataract Surgery.
NCT06710977 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C
NCT00346489 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco
NCT04396301 ·Status: COMPLETED ·Phase: PHASE3
-
Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea
NCT04140422 ·Status: COMPLETED ·Phase: NA
-
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.
NCT01475643 ·Status: COMPLETED ·Phase: PHASE3
-
Diclofenac vs Dexamethasone in Combined Surgery
NCT00825864 ·Status: COMPLETED ·Phase: NA
-
Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery
NCT00690222 ·Status: TERMINATED ·Phase: NA
-
RELIEF OF PSYCHOEMOTIONAL STRESS USING XENON SEDATION
NCT06080100 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Topical 0.4% Ketorolac and Vitreoretinal Surgery
NCT00576329 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
NCT01023724 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
NCT00170729 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
NCT01193504 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Effects and Safety of 3% Diquafosol After Cataract Surgery
NCT02608489 ·Status: COMPLETED ·Phase: NA